1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. Medicure Acquires Marley Drug

Add-on Acquisition • Information Technology

Medicure Acquires Marley Drug

On December 17, 2020, Medicure acquired information technology company Marley Drug for 6M USD

Acquisition Context
  • This is Medicure’s 1st transaction in the Information Technology sector.
  • This is Medicure’s 3rd largest (disclosed) transaction.
  • This is Medicure’s 3rd transaction in the United States.
  • This is Medicure’s 1st transaction in North Carolina.

Explore All 9666 Add-on Acquisition Information Technology Deals - Search the Database Free


M&A Deal Summary
Date December 17, 2020
Target Marley Drug
Sector Information Technology
Buyer(s) Medicure
Deal Type Add-on Acquisition
Deal Value 6M USD

Target Company

Marley Drug

Winston-Salem, North Carolina, United States
Marley Drug, Inc. is a provider of an advanced operating systems include automated pill dispensing, an extended supply generic drug program, and an effective customer communication system. Marley Drug is based in Winston-Salem, North Carolina.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Medicure

Winnipeg, Manitoba, Canada
Category Company
Founded 1997
Sector Life Science
Revenue 22M CAD (2024)
DESCRIPTION

Medicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market. Medicure was founded in 1997 and is based in Winnipeg, Manitoba.

Deal Context for Buyer #
Overall 3 of 5
Sector: Information Technology 1 of 1
Type: Add-on Acquisition 2 of 4
State: North Carolina 1 of 1
Country: United States 3 of 5
Year: 2020 1 of 1
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-30 Zypitamag

United States

Zypitamag is an HMG-CoA reductase inhibitor indicated for adult patients with primary hyperlipidemia or mixed dyslipidemia as adjunctive therapy to diet, to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C)

Buy $7M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-18 Gateway Medical Pharmacy

Portland, Oregon, United States

Gateway Medical Pharmacy offers compounding medications and is a full service long-term care pharmacy. Gateway Medical Pharmacy is based in Portland, Oregon.

Buy -

Explore Related M&A Activity

Information Technology M&A - Add-on Acquisition M&A Deals - North Carolina M&A - United States M&A - 2020 M&A

Mergr

Solution for

Product

Company

Legal